The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

A recent study published in the Lancet Diabetes & Endocrinology journal states that weight loss drugs can lower kidney ...

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...

including semaglutide (also known as Ozempic or Wegovy), dulaglutide (Trulicity) and liraglutide (Victoza). The results showed that compared to placebo, GLP-1 receptor agonists reduced the risk of ...

The thyroid medication levothyroxine may be associated with bone loss, according to a study that will be presented at the ...

Giovanni E. Ferreira, University of Sydney and Christina Abdel Shaheed, University of Sydney The drug semaglutide, commonly ...

“They also have benefits for heart and kidney health, which has led to their use in patients with certain heart conditions or ...